Ketorolac in Neuropathic Pain

Journal of Pain and Symptom Management

Volumn 32, Issue 3, 2006, Pages 202-204

  Kausar, Fariha ^a   Davis, Mellar P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLODYNIA; BRACHIAL PLEXUS; BREAST CANCER; BURNING SENSATION; CASE REPORT; DRUG RESPONSE; FEMALE; HUMAN; LETTER; NEUROPATHIC PAIN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRACHIAL PLEXUS NEUROPATHIES; BREAST NEOPLASMS; CARCINOMA, ADENOSQUAMOUS; FEMALE; HUMANS; KETOROLAC; LYMPHATIC METASTASIS; MIDDLE AGED; NEURALGIA; TREATMENT OUTCOME;

EID: 33747893487     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.05.004     Document Type: Letter

References (9)

1. Ripamonti C., Ticozzi C., Zecca E., Rodriguez C.H., and DeConno F. Continuous subcutaneous infusion of ketorolac in cancer neuropathic pain unresponsive to opioid and adjuvant drugs. A case report. Tumori 82 (1996) 413-415
2. Gillis J.C., and Brogden R.N. Ketorolac-a reappraisal of its pharmacodynamic and pharmacologic properties and therapeutic use in pain management. Drugs 53 1 (1997) 139-188
3. Myers K.G., and Trotman I.F. Use of ketorolac by continuous subcutaneous infusion for the control of cancer-related pain. Postgrad Med J 70 (1994) 359-362
4. Namaka M., Gramlich C.R., Ruhlen D., Melanson M., Sutton I., et al. A treatment algorithm for neuropathic pain. Clin Ther 26 7 (2004) 951-979
5. Katafuchi T., Duan S., Take S., and Yoshimura M. Modulation of glutamate-induced outward current by prostaglandin E (2) in rat dissociated preoptic neurons. Brain Res 1037 1-2 (2005) 180-186
6. Syriatowicz J.P., Hu D., Walker J.S., and Tracey D.J. Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience 94 2 (1999) 587-594
7. Ma W., and Eisenach J.C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 15 (2002) 1037-1047
8. Mercadante S., Fulfaro F., and Casuccio A. A randomized controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer 38 (2002) 1358-1363
9. Joishy S.K., and Walsh D. The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic pain: application in bone metastases and the opioid bowel syndrome. J Pain Symptom Manage 16 (1995) 334-339